A practical reference on Selank: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-12 and is reviewed periodically as new material appears.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
| Property | Value | Notes |
|---|---|---|
| Principal proposed target | GABA-A receptor complex | Hypothesis derived mainly from animal pharmacology |
| Common behavioral assay | Elevated plus maze | Rodent test for anxiety-like behavior |
| Reported molecular marker | Hippocampal BDNF expression | Measured by immunoassay or mRNA quantification |
| Typical dosing route | Intranasal | Chosen to reduce first-pass metabolism |
| Reported plasma half-life | Minutes | Based on limited peptide stability data |
Quality assessment of Selank samples typically combines purity determination with identity confirmation and counter-ion analysis. Purity is usually reported as a percentage by chromatographic area, with values above 95 percent often quoted for research-grade material. Water content and residual solvents are checked in lyophilized batches because they affect both stability and accurate mass determination. A reported purity figure does not by itself establish that a sample is the intended sequence, so orthogonal methods are needed to rule out sequence isomers or truncation products.
Characterization of Selank in laboratory settings relies on standard peptide analytical techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and degradation products, while mass spectrometry confirms molecular identity through accurate mass measurement. Amino acid analysis and peptide sequencing verify the primary structure when reference material is unavailable. Because Selank is a short chain, fragmentation-based analysis produces a diagnostic ion pattern that supports confident identification.
Peptide stability depends strongly on temperature, moisture, and pH. Lyophilized Selank is generally most stable when stored cold and dry, with freezer temperatures commonly used for long-term storage. In solution, the compound is susceptible to hydrolysis and to microbial growth if it is not handled aseptically. The C-terminal proline-rich extension appears to slow enzymatic cleavage relative to tuftsin, though quantitative degradation rates vary with the matrix and the conditions tested. Published stability data specific to Selank remain sparse.
Naming conventions place Selank in the same research family as Semax, another Russian-developed peptide investigated for cognitive effects. The two compounds share a lineage but differ in sequence and in the biological systems proposed as their targets. Semax descends from ACTH fragments, whereas Selank descends from tuftsin. Publications sometimes identify Selank by its full peptide sequence or by laboratory codes rather than one uniform trade name. Because replication outside Russia is limited, reports on its properties are best read alongside the study design and the purity of the material tested.
Selank is a synthetic heptapeptide developed in Russia during the 1990s. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences designed it as a stabilized analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide. The compound has been studied primarily for its reported anxiolytic and nootropic effects. It remains largely unknown in Western pharmacology and is not approved as a medicine by major regulators such as the FDA or the EMA.
The better way of removing ammonium sulfate from the protein is mixing the precipitate protein in a buffer containing a mixture of SDS, Tris-HCl, and phenol and centrifuging the mixture. The precipitate that comes out of this centrifugation will contain salt-less concentrated protein.
== Column set == The set of columns can be configured with various types. In the original work, column sets were mainly poly(dimethylsiloxane) in the first dimension and poly(ethyleneglycol) in the second dimension. These so-called straight phase column sets are suitable for hydrocarbon analysis. Therefore, these are still used most frequently in the oil and gas industry. For applications that require the analysis of polar compounds in a non-polar matrix, a reverse-phase column set gives more resolution. The first dimension column in this situation is a polar column, followed by a mid-polar second dimension column. Other applications can be configured differently according to their specific needs. For example, they may include chiral columns for optical isomer separation or PLOT columns for volatiles and gas samples.
=== Early warning systems === Germany, Austria and Switzerland, among many other countries, have early warning systems in place to protect the population. The local dose rate measurement network (ODL measurement network) is a measurement system for radioactivity operated by the German Federal Office for Radiation Protection, which determines the local dose rate at the measurement site. In Austria, the Radiation Early Warning System is a measurement and reporting system established in the late 1970s to provide early detection of elevated levels of ionizing radiation in the country and to enable the necessary measures to be taken. The readings are automatically sent to the central office at the Ministry, where they can be accessed by the relevant departments, such as the Federal Warning Center or the warning centers of the federal states. NADAM (Network for Automatic Dose Alerting and Measurement) is the gamma radiation monitoring network of the Swiss National Emergency Operations Center. The monitoring network is complemented by the MADUK stations (Monitoring Network for Automatic Dose Rate Monitoring in the Environment of Nuclear Power Plants) of the Swiss Federal Nuclear Safety Inspectorate (ENSI).
Compton had recently founded the American Research and Development Corporation (ARD) to spur the formation of new post-war industries. He introduced the founders to ARD's president, Georges Doriot. Doriot predicted the cancer treatment machines would be a commercial failure. Nevertheless, he perceived HVEC's leaders to be technically capable, and Compton persuaded him that ARD should have a startup with clear human benefits. Among more than 400 applications, Doriot selected the firm among ARD's first three investments. He offered the founders $200,000 in initial capitalization, leaving half the equity to them and their staff consultants. Compton arranged for HVEC to exclusively license MIT's Van de Graaff and Trump patents. Both Compton and Doriot served on the new company's board.
Sources: en.wikipedia.org
On July 28, 2019, during the XXV São Paulo Forum hosted in Caracas, Nicolás Maduro declared that the FARC-EP dissident leaders Iván Márquez and Jesús Santrich were "welcome" in Venezuela and to the São Paulo Forum.
==== Stages of genital development ==== The first stage occurs roughly four weeks before the spider's final molt. Unlike adult males, young males possess a broad tarsus that does not appear to consist of any internal structures or appendages. Their pedipalps are greatly bent at a joint connecting the between the tibia and patella. The testes at this point in the young male's life appear very similar to those of the adult males both in terms of physical structure and presence of all stages of spermatogenesis. This spermatogenesis takes place in cysts which contain spermatids. During this time, there is very little observable secretory activity in the testes. In a similar manner to the adult genital system, the vas deferens in young males is connected to the distal, thin part of the testis. The distal portion of the vas deferens is incredibly narrow and is not characterized by the presence of spermatozoa or other secretions. On the other hand, the proximal region consists of a thick epithelium and intricate luminal region containing spermatozoa. The second stage of development is observed two weeks prior the spider's final molt. At this point, the pedipalps of the spider are only partially bent, and the internal structures of the tarsus can be seen. The testes are dimensionally very similar to those of subadult stage one males and adult males. The distal portion of the vas deferens becomes thinner and twists in a tube-like shape. Spermatozoa and other secretions are extensively present in proximal portion of the vas deferens.
Due to the wide array of options in the seafood marketplace, seafood is far more susceptible to mislabeling than terrestrial food. There are more than 1,700 species of seafood in the United States' consumer marketplace, 80–90% of which are imported and less than 1% of which are tested for fraud. However, more recent research into seafood imports and consumption patterns among consumers in the United States suggests that 35%–38% of seafood products are of domestic origin. consumption suggests Estimates of mislabelled seafood in the United States range from 33% in general up to 86% for particular species. Byzantine supply chains, frequent bycatch, brand naming, species substitution, and inaccurate ecolabels all contribute to confusion for the consumer. A 2013 study by Oceana found that one third of seafood sampled from the United States was incorrectly labeled. Snapper and tuna were particularly susceptible to mislabelling, and seafood substitution was the most common type of fraud. Another type of mislabelling is short-weighting, where practices such as overglasing or soaking can misleadingly increase the apparent weight of the fish. For supermarket shoppers, many seafood products are unrecognisable fillets. Without sophisticated DNA testing, there is no foolproof method to identify a fish species without their head, skin, and fins. This creates easy opportunities to substitute cheap products for expensive ones, a form of economic fraud. Beyond financial concerns, significant health risks arise from hidden pollutants and marine toxins in an already fraught marketplace.
Bird conservation requires specialized knowledge in aspects of biology and ecology, and may require the use of very location-specific approaches. Ornithologists contribute to conservation biology by studying the ecology of birds in the wild and identifying the key threats and ways of enhancing the survival of species. Critically endangered species such as the California condor have had to be captured and bred in captivity. Such ex situ conservation measures may be followed by reintroduction of the species into the wild.
Researchers with the biotechnology company Rejuvenate Bio managed to extend the lifespans of elderly mice by 109%, reverse age-related frailty in the mice, and achieve signs of age reversal in human skin cells with gene therapy, employing partial cellular reprogramming.
Sources: en.wikipedia.org
Intranasal administration predominates in both animal and human research because it avoids hepatic first-pass metabolism. Injectable and intraperitoneal routes appear in animal work mainly for comparison.
Behavioral endpoints include time spent in open arms of the elevated plus maze and avoidance latencies. Biochemical endpoints include BDNF concentration, cytokine levels, and monoamine metabolite ratios in brain tissue.
Most published studies are small, originate from a limited number of laboratories, and lack independent replication. Dose-response relationships, measured brain exposure, and long-term outcomes are not well characterized.
Selank is a synthetic seven-amino-acid peptide modeled on tuftsin, a fragment of the immunoglobulin G heavy chain. It was designed in Russia to combine anxiolytic and immunomodulatory properties in one molecule.